Spend on new drugs expected to drop
The drugs industry expects the NHS to cut its real terms spend on new medicines over the next three years - but it is warning that the slow adoption of new drugs could create avoidable costs.
Continue reading this article – simply subscribe below
Subscribe now for instant access to hsj.co.uk and our mobile site. Choose the package that suits you and get the weekly magazine, iPad app or both.
If you are a Health Service Journal subscriber please sign in with your email address and click submit: